BRISTOL-MYERS SQUIBB CO (BRM.DE) Stock Fundamental Analysis
FRA:BRM • US1101221083
52.68 EUR
+1.13 (+2.19%)
Last: Feb 27, 2026, 07:00 PM
BRM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 49 industry peers in the Pharmaceuticals industry. BRM has an excellent profitability rating, but there are some minor concerns on its financial health. BRM has a bad growth rate and is valued cheaply. BRM also has an excellent dividend rating. This makes BRM very considerable for value and dividend investing!
1. Profitability
1.1 Basic Checks
- In the past year BRM was profitable.
- BRM had a positive operating cash flow in the past year.
- Of the past 5 years BRM 4 years were profitable.
- Each year in the past 5 years BRM had a positive operating cash flow.
1.2 Ratios
- BRM has a Return On Assets (7.83%) which is comparable to the rest of the industry.
- BRM has a better Return On Equity (38.19%) than 88.46% of its industry peers.
- BRM has a better Return On Invested Capital (19.52%) than 78.85% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for BRM is in line with the industry average of 13.98%.
- The last Return On Invested Capital (19.52%) for BRM is above the 3 year average (14.47%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROIC | 19.52% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1.3 Margins
- BRM has a Profit Margin (14.64%) which is comparable to the rest of the industry.
- BRM's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 35.82%, BRM belongs to the top of the industry, outperforming 86.54% of the companies in the same industry.
- In the last couple of years the Operating Margin of BRM has grown nicely.
- BRM has a Gross Margin (72.63%) which is comparable to the rest of the industry.
- BRM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% |
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BRM is creating value.
- BRM has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, BRM has less shares outstanding
- Compared to 1 year ago, BRM has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.57 indicates that BRM is not a great score, but indicates only limited risk for bankruptcy at the moment.
- BRM has a Altman-Z score (2.57) which is in line with its industry peers.
- BRM has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as BRM would need 3.51 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 3.51, BRM is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
- A Debt/Equity ratio of 2.33 is on the high side and indicates that BRM has dependencies on debt financing.
- BRM has a worse Debt to Equity ratio (2.33) than 80.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 2.57 |
ROIC/WACC2.27
WACC8.59%
2.3 Liquidity
- A Current Ratio of 1.26 indicates that BRM should not have too much problems paying its short term obligations.
- BRM has a worse Current ratio (1.26) than 61.54% of its industry peers.
- A Quick Ratio of 1.14 indicates that BRM should not have too much problems paying its short term obligations.
- The Quick ratio of BRM (1.14) is better than 65.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
- BRM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 439.47%, which is quite impressive.
- BRM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.92% yearly.
- BRM shows a decrease in Revenue. In the last year, the revenue decreased by -0.22%.
- BRM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.54% yearly.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
3.2 Future
- BRM is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.54% yearly.
- The Revenue is expected to decrease by -5.62% on average over the next years.
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 10.11, the valuation of BRM can be described as very reasonable.
- BRM's Price/Earnings ratio is rather cheap when compared to the industry. BRM is cheaper than 88.46% of the companies in the same industry.
- BRM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.07.
- With a Price/Forward Earnings ratio of 10.22, the valuation of BRM can be described as very reasonable.
- BRM's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRM is cheaper than 82.69% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 28.05, BRM is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.11 | ||
| Fwd PE | 10.22 |
4.2 Price Multiples
- BRM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRM is cheaper than 86.54% of the companies in the same industry.
- BRM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BRM is cheaper than 94.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.86 | ||
| EV/EBITDA | 7.53 |
4.3 Compensation for Growth
- BRM has a very decent profitability rating, which may justify a higher PE ratio.
- BRM's earnings are expected to decrease with -3.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
5. Dividend
5.1 Amount
- BRM has a Yearly Dividend Yield of 4.12%, which is a nice return.
- BRM's Dividend Yield is rather good when compared to the industry average which is at 1.84. BRM pays more dividend than 88.46% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, BRM pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.12% |
5.2 History
- On average, the dividend of BRM grows each year by 6.51%, which is quite nice.
Dividend Growth(5Y)6.51%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
- BRM pays out 71.52% of its income as dividend. This is not a sustainable payout ratio.
- The Dividend Rate of BRM has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
FRA:BRM (2/27/2026, 7:00:00 PM)
52.68
+1.13 (+2.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)04-30 2026-04-30
Inst Owners81.87%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap107.24B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.59
Price Target52.4 (-0.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.12% |
Yearly Dividend2.13
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)7.49%
PT rev (3m)14.09%
EPS NQ rev (1m)1.09%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)0.24%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)3.32%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)6.84%
Revenue NY rev (3m)7.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.11 | ||
| Fwd PE | 10.22 | ||
| P/S | 2.63 | ||
| P/FCF | 9.86 | ||
| P/OCF | 8.94 | ||
| P/B | 6.85 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.53 |
EPS(TTM)5.21
EY9.89%
EPS(NY)5.15
Fwd EY9.79%
FCF(TTM)5.34
FCFY10.15%
OCF(TTM)5.89
OCFY11.18%
SpS20.05
BVpS7.69
TBVpS-9.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROCE | 25.91% | ||
| ROIC | 19.52% | ||
| ROICexc | 23.22% | ||
| ROICexgc | 84.94% | ||
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% | ||
| FCFM | 26.65% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 2.03 | ||
| Cap/Depr | 32.69% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 8.22 | ||
| Cash Conversion | 66.54% | ||
| Profit Quality | 182.1% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 2.57 |
F-Score7
WACC8.59%
ROIC/WACC2.27
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.78%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%
BRISTOL-MYERS SQUIBB CO / BRM.DE FAQ
What is the fundamental rating for BRM stock?
ChartMill assigns a fundamental rating of 5 / 10 to BRM.DE.
What is the valuation status of BRISTOL-MYERS SQUIBB CO (BRM.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to BRISTOL-MYERS SQUIBB CO (BRM.DE). This can be considered as Undervalued.
How profitable is BRISTOL-MYERS SQUIBB CO (BRM.DE) stock?
BRISTOL-MYERS SQUIBB CO (BRM.DE) has a profitability rating of 7 / 10.
What is the expected EPS growth for BRISTOL-MYERS SQUIBB CO (BRM.DE) stock?
The Earnings per Share (EPS) of BRISTOL-MYERS SQUIBB CO (BRM.DE) is expected to decline by -1.05% in the next year.
Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?
The dividend rating of BRISTOL-MYERS SQUIBB CO (BRM.DE) is 7 / 10 and the dividend payout ratio is 71.52%.